Skip to content

Arteriovenous Fistula Maturation Evaluation Study. FAME Study

Study of the Hemodynamic and Clinical Maturation of the Native Arteriovenous Fistula for Hemodialysis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04736875
Enrollment
86
Registered
2021-02-03
Start date
2019-02-01
Completion date
2022-02-20
Last updated
2022-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage Renal Disease, Hemodialysis Access Failure, Native Arteriovenous Fistula, Vascular Access Maturation

Keywords

hemodialysis, native arteriovenous fistula, maturation, feeding artery, efferent vein

Brief summary

Study of the features of hemodynamic and clinical maturation of the native arteriovenous fistula for hemodialysis.

Detailed description

This is a prospective, single-center, observational study, investigating the clinical and hemodynamic features of maturation of hemodialysis native arteriovenous fistula (AVF). Hemodynamic features under investigation are the diameter of the feeding brachial artery, volume of flow (VF) measured with transcutaneous Duplex ultrasound (DUS), resistivity index (RI), diameter and wall thickness of the efferent vein, measured at days 1, 2, 3, 4, 5, 6, 7, 14, 21, 30, 60 and 90 post creation. Clinical features of maturation are the time of first access successful cannulation and the performance of three consecutive adequate dialysis sessions.

Interventions

DIAGNOSTIC_TESTDoppler ultrasound study

Transcutaneous Doppler ultrasound (DUS) study was performed at the mid brachial artery to assess diameter, VF and RI, and at the mid segment of the efferent vein to assess the diameter and wall thickness.

Sponsors

National and Kapodistrian University of Athens
CollaboratorOTHER
Democritus University of Thrace
CollaboratorOTHER
Medifil AE
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

1. Hemodialysis patients 2. new native arteriovenous fistula (AVF)

Exclusion criteria

1. Patients not eligible for AVF creation 2. Patients with non compensated heart failure New York Heart Association stages 3 and 4

Design outcomes

Primary

MeasureTime frameDescription
Wall thickness of the efferent veinday 1 post access creationWall thickness of the efferent vein in mm
Volume flowday 1 post access creationVolume of flow in brachial artery in L/min
brachial artery diameterday 1 post access creationDiameter of the Brachial artery in mm
Resistive index RIday 1 post access creationCalculation of the Resistive Index of the Brachial artery
Diameter of the efferent veinday 1 post access creationDiameter of the the efferent vein in mm

Secondary

MeasureTime frameDescription
Successful hemodialysis30 and 60 daysThree consecutive adequate hemodialysis sessions based on measurement of single pool kt/V
Primary patency6 monthsPercentage of total patent arteriovenous fistulae without the need of additional interventions assessed by transcutaneous dopler ultrasound
Surgeon-Nephrologist access site selection concordanceAt access creation (day 0)Record of the opinion regarding the site of vascular access creation between the nephrologist performing preoperative mapping and the surgeon performing access creation with the use of a questionaire
Time of first successful cannulation30 and 60 daysTime period between access creation and first successful cannulation for hemodialysis

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026